Archive: 15/01/2016
Merck pays $830 M to settle class-action case over Vioxx
The drugmaker Merck is paying $830 million to resolve a federal class-action lawsuit involving shareholders and the painkiller Vioxx, which was pulled from the market years ago over safety concerns.
Jan 15, 2016
Fears mount in Nigeria over Lassa outbreak, response
At least 44 people have died from Lassa fever in Nigeria with the death toll expected to rise, underscoring the difficulty in combating deadly viruses in a region still reeling from Ebola.
Jan 15, 2016
Study shows less physically mature ice hockey players have prolonged concussion symptoms
A study led by a Hasbro Children's Hospital sports medicine physician found that male student ice hockey players in earlier pubertal stages had a significantly increased risk of prolonged symptoms from concussion compared ...
Jan 15, 2016